This trial is testing whether a new machine that uses MRI scans to guide radiotherapy treatments can safely acquire high quality images.
1 Primary · 1 Secondary · Reporting Duration: Through study completion, approximately 1 year
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: MR Imaging on the Alberta linac-MR P3 system · No Placebo Group · N/A
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: